CAPE GIRARDEAU, Mo. (KFVS) - It’s easy to find information about breast cancer online. It can be just as easy to find misinformation. April Ostendorf-Morris is an advanced practice nurse at the Saint ...

T cell therapy, which uses a patient's own immune cells to fight cancer, has emerged as a powerful way to treat lymphoma and other blood cancers.

Oct. 2—Jessica Katawick's whole life changed on a September morning in 2020. "As soon as my feet hit the floor something said I should just do a breast exam today. I just knew it was breast cancer," ...

In recognition of Breast Cancer Awareness Month, join us for a live webinar to uncover the complexity of tumor biology and the surprising resilience of normal tissue. This event will feature ...

UCSF researchers are advancing care through scientific breakthroughs that pave the way for less addictive pain medications and better treatments for cancer and Alzheimer’s.

WJAC provides news, weather and sports information for Johnstown, Altoona, State College and DuBois, Pennsylvania. Our coverage area includes Bedford, Everett, Somerset, Meyersdale, Ebensburg, Windber ...

A genetic risk score could one day help women with DCIS or LCIS know if they are high or low risk and decide which treatment option is best for their individual case.

Community MD Anderson Cancer Center launched its stem cell transplant program in 2024, admitting its first patients in the fall. The Stem Cell Transplant and Cellular Therapy Institute, located on the ...

The U.S. Food and Drug Administration (FDA) has approved Zepzelca (lurbinectedin) in combination with Tecentriq (atezolizumab) or Tecentriq Hybreza (atezolizumab and hyaluronidase-tqjs) for the ...

In 2020, right when Jane Baude was starting her Ph.D. research at UC Santa Barbara, she learned that a critical component of her experiment—the gel needed to grow and test mammary epithelial ...

REPAIRome specifically addresses the repair of one of the most serious types of DNA damage, DNA double-strand breaks (DSBs).

The ESMO 2025 Congress will highlight late-breaking abstracts on RCC and bladder cancer, focusing on immune checkpoint inhibitors and investigational combinations. Key trials include RAMPART for RCC ...